These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10517905)

  • 1. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.
    Thiele K; Bierhaus A; Autschbach F; Hofmann M; Stremmel W; Thiele H; Ziegler R; Nawroth PP
    Gut; 1999 Nov; 45(5):693-704. PubMed ID: 10517905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear factor kappa B inflammatory bowel disease.
    Schreiber S; Nikolaus S; Hampe J
    Gut; 1998 Apr; 42(4):477-84. PubMed ID: 9616307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
    Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP
    Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.
    Guidi L; Costanzo M; Ciarniello M; De Vitis I; Pioli C; Gatta L; Pace L; Tricerri A; Bartoloni C; Coppola L; Balistreri P; Doria G; Fedeli G; Gasbarrini GB
    Int J Immunopathol Pharmacol; 2005; 18(1):155-64. PubMed ID: 15698520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
    Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
    Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
    Gan HT; Chen YQ; Ouyang Q
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.
    Schiekofer S; Rudofsky G; Andrassy M; Schneider J; Chen J; Isermann B; Kanitz M; Elsenhans S; Heinle H; Balletshofer B; Häring HU; Schleicher E; Nawroth PP; Bierhaus A
    Diabetes Obes Metab; 2003 Jul; 5(4):251-61. PubMed ID: 12795658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.
    Segain JP; Raingeard de la Blétière D; Bourreille A; Leray V; Gervois N; Rosales C; Ferrier L; Bonnet C; Blottière HM; Galmiche JP
    Gut; 2000 Sep; 47(3):397-403. PubMed ID: 10940278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.
    Bantel H; Schmitz ML; Raible A; Gregor M; Schulze-Osthoff K
    FASEB J; 2002 Nov; 16(13):1832-4. PubMed ID: 12223450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
    Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
    J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells.
    Song Y; Hong J; Liu D; Lin Q; Lai G
    Scand J Immunol; 2013 Feb; 77(2):109-16. PubMed ID: 23126502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of NF-κBp65 and IκBα in gestational trophoblastic disease and clinical significance].
    Ju LL; Liu HN; Cai JT; Xu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1084-7. PubMed ID: 23046941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of IkappaBalpha increases the expression of matrix metalloproteinase-2 in human ciliary muscle cells.
    Lan YQ; Zhang C; Xiao JH; Zhuo YH; Guo H; Peng W; Ge J
    Mol Vis; 2009 Sep; 15():1977-87. PubMed ID: 19816602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.
    Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
    Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression.
    Wild GE; Waschke KA; Bitton A; Thomson AB
    Aliment Pharmacol Ther; 2003 Aug; 18(3):309-17. PubMed ID: 12895215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin II and aldosterone on NF-kappaB binding activity in hepatic stellate cells].
    Li X; Meng Y; Jiang B; Yang XS; Wang WW; Guo D; Lai ZS; Zhang ZS
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):374-80. PubMed ID: 15854525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.